Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research

EQS-Media / 03.03.2025 / 17:12 CET/CEST

Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research

The Alzchem Group is once again bringing together the brightest minds in creatine research in 2025 – in the heart of Munich. From March 12 to 15, 2025, the Meliá Hotel will be transformed into a meeting place for scientists, health and nutrition experts, and anyone else interested in learning more about the versatile benefits of creatine.

The conference will be held in a hybrid format – live on site and online – so that everyone can attend.

The event is organized by the Creatine for Health Scientific Advisory Board of Alzchem Group AG, the Exercise and Sport Nutrition Laboratory of Texas A&M University and the DBSS Research Division. Together, they provide a high-level platform to highlight the latest findings and innovations in creatine supplementation, from performance enhancement to longevity.

The future starts here
On all four days of the event, participants can look forward to exciting expert presentations on topics such as:

• Creatine as a way to combat fatigue symptomes
• The role of creatine in women’s health
• Creatine to support general well-being
• How creatine can support cognitive performance
• Creatine for a healthy ageing

The program will be complemented by interactive panel discussions – a perfect opportunity to engage with experts, gain new insights and immerse yourself in the world of creatine research.

Expertise, innovation and networking
“We at the Alzchem Group are thrilled to be bringing the Creatine Conference 2025 to Munich. This is where the most renowned minds in science, medicine and sports nutrition gather to present groundbreaking discoveries and actively shape the future of health and well-being. This conference is a must for anyone interested in the many uses of creatine – be it for athletic performance, cognitive function or general well-being,” says Martina Spitzer, CSO of the Alzchem Group.

The organizers warmly invite experts from the fields of medicine, nutrition, sports science and wellness, as well as young researchers, business delegates and students. Of course, all other interested parties are always welcome. Participants can earn credits for continuing education units (CEUs) and continuing medical education (CMEs).

Learn from the best: how to participate
Do you want to be there and benefit from the latest findings? Further information on registration and the detailed program is available here.

You also have the opportunity to participate in the Creatine Conference 2025 online.

Find out more and get your ticket now.

Do you have research to share? Submit your abstract now! Deadline: February 17, 2025
https://forms.gle/kDfLj2kRkhCTnKdS9

For more information, visit:
www.creatineforhealth.com
Creatine For Health - YouTube

New book “Creatine – Muscle Metabolism, Fitness, Health & Longevity” explains the many benefits of creatine
Creatine is much more than just a supplement for athletes: the substance plays a central role in muscle metabolism and offers numerous health benefits. The new book “Creatine – Muscle Metabolism, Fitness, Health & Longevity” by Prof. Dr. Jürgen Giessing and Dr. Robert Percy Marshall provides a well-founded, easy-to-understand presentation of the latest scientific findings on creatine and its many possible applications.

About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments.

The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.

Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.

The company employs around 1,730 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 554.2 million and EBITDA of EUR 105.3 million in 2024.

End of Media Release

03.03.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:

English

Company:

Alzchem Group AG

Dr.-Albert-Frank-Str. 32

83308 Trostberg

Germany

Phone:

+498621862888

Fax:

+49862186502888

E-mail:

ir@alzchem.com

Internet:

www.alzchem.com

ISIN:

DE000A2YNT30

WKN:

A2YNT3

Indices:

SDAX

Listed:

Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart

EQS News ID:

2094409

End of News

EQS Media

2094409 03.03.2025 CET/CEST